DEFINITIVE PROXY

Company

Senti Biosciences, Inc.

Filed

April 30, 2025

Period of Report

June 25, 2025

Accession Number

0001854270-25-000054

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →